Radotinib
CAS: 926037-48-1
Ref. TM-T2328
| 5mg | 46.00 € | ||
| 10mg | 64.00 € | ||
| 25mg | 118.00 € | ||
| 50mg | 185.00 € | ||
| 100mg | 346.00 € | ||
| 500mg | 807.00 € | ||
| 1ml*10 (DMSO) | 49.00 € |
Estimated delivery in United States, on Thursday 16 May 2024
Product Information
Name:
Radotinib
Synonyms:
- IY-5511, Supect
- 4-Methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(2-pyrazinyl)-2-pyrimidinyl]amino]benzamide
- 4-Methyl-N-[3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl]-3-(4-(pyrazin-2-yl)pyrimidin-2-ylamino)benzamide
- Benzamide, 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(2-pyrazinyl)-2-pyrimidinyl]amino]-
- Unii-I284Ljy110
CAS:
Description:
Radotinib (IY-5511), and sometimes referred to by its investigational name IY5511, is a drug for the treatment of different types of Y, most notably Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) with resistance or intolerance of other tyrosine kinase Bcr-Abl inhibitors
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
530.5
Formula:
C27H21F3N8O
Purity:
99.97%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T2328 Radotinib
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
